Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A dual-channel endoscope for quantitative imaging, monitoring, and triggering of doxorubicin release from liposomes in living mice.

Kress J, Rohrbach DJ, Carter KA, Luo D, Poon C, Aygun-Sunar S, Shao S, Lele S, Lovell JF, Sunar U.

Sci Rep. 2017 Nov 14;7(1):15578. doi: 10.1038/s41598-017-15790-y.

2.

Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.

Mett V, Komarova EA, Greene K, Bespalov I, Brackett C, Gillard B, Gleiberman AS, Toshkov IA, Ayg├╝n-Sunar S, Johnson C, Karasik E, Bapardekar-Nair M, Kurnasov OV, Osterman AL, Stanhope-Baker PS, Morrison C, Moser MT, Foster BA, Gudkov AV.

Oncogene. 2018 Jan 25;37(4):439-449. doi: 10.1038/onc.2017.346. Epub 2017 Oct 2.

3.

Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody.

Frescas D, Roux CM, Aygun-Sunar S, Gleiberman AS, Krasnov P, Kurnasov OV, Strom E, Virtuoso LP, Wrobel M, Osterman AL, Antoch MP, Mett V, Chernova OB, Gudkov AV.

Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):E1668-E1677. doi: 10.1073/pnas.1614661114. Epub 2017 Feb 13.

4.

A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity.

Leigh ND, Bian G, Ding X, Liu H, Aygun-Sunar S, Burdelya LG, Gudkov AV, Cao X.

PLoS One. 2014 Jan 14;9(1):e85587. doi: 10.1371/journal.pone.0085587. eCollection 2014.

5.

Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.

Burdelya LG, Brackett CM, Kojouharov B, Gitlin II, Leonova KI, Gleiberman AS, Aygun-Sunar S, Veith J, Johnson C, Haderski GJ, Stanhope-Baker P, Allamaneni S, Skitzki J, Zeng M, Martsen E, Medvedev A, Scheblyakov D, Artemicheva NM, Logunov DY, Gintsburg AL, Naroditsky BS, Makarov SS, Gudkov AV.

Proc Natl Acad Sci U S A. 2013 May 14;110(20):E1857-66. doi: 10.1073/pnas.1222805110. Epub 2013 Apr 29.

6.

A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.

Ding X, Bian G, Leigh ND, Qiu J, McCarthy PL, Liu H, Aygun-Sunar S, Burdelya LG, Gudkov AV, Cao X.

J Immunol. 2012 Nov 15;189(10):4719-27. doi: 10.4049/jimmunol.1201206. Epub 2012 Oct 8.

7.

Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy.

Burdelya LG, Gleiberman AS, Toshkov I, Aygun-Sunar S, Bapardekar M, Manderscheid-Kern P, Bellnier D, Krivokrysenko VI, Feinstein E, Gudkov AV.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):228-34. doi: 10.1016/j.ijrobp.2011.05.055. Epub 2011 Oct 14.

8.

Structural characterization of the polar lipids of Clostridium novyi NT. Further evidence for a novel anaerobic biosynthetic pathway to plasmalogens.

Guan Z, Johnston NC, Aygun-Sunar S, Daldal F, Raetz CR, Goldfine H.

Biochim Biophys Acta. 2011 Mar;1811(3):186-93. doi: 10.1016/j.bbalip.2010.12.010. Epub 2010 Dec 30.

9.

A glimpse into the proteome of phototrophic bacterium Rhodobacter capsulatus.

Onder O, Aygun-Sunar S, Selamoglu N, Daldal F.

Adv Exp Med Biol. 2010;675:179-209. doi: 10.1007/978-1-4419-1528-3_11.

10.

A phosphoethanolamine-modified glycosyl diradylglycerol in the polar lipids of Clostridium tetani.

Johnston NC, Aygun-Sunar S, Guan Z, Ribeiro AA, Daldal F, Raetz CR, Goldfine H.

J Lipid Res. 2010 Jul;51(7):1953-61. doi: 10.1194/jlr.M004788. Epub 2010 Feb 20.

11.

Rhodobacter capsulatus OlsA is a bifunctional enzyme active in both ornithine lipid and phosphatidic acid biosynthesis.

Aygun-Sunar S, Bilaloglu R, Goldfine H, Daldal F.

J Bacteriol. 2007 Dec;189(23):8564-74. Epub 2007 Oct 5.

12.

Ornithine lipid is required for optimal steady-state amounts of c-type cytochromes in Rhodobacter capsulatus.

Aygun-Sunar S, Mandaci S, Koch HG, Murray IV, Goldfine H, Daldal F.

Mol Microbiol. 2006 Jul;61(2):418-35.

Supplemental Content

Loading ...
Support Center